Revenue fell 41.87% year-over-year to ¥895.74 million due to divestitures, while net profit dropped 3.05% to ¥315.97 million. The company acquired Green Cross (Hong Kong) to expand plasma supply and approved an interim dividend of ¥1.60 per 10 shares.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.